2022 annual financial data
Agios Pharmaceuticals 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -2,173.3%.
Operating income was -389,047,000 USD and net income was -231,801,000 USD.
Operating cash flow was -309,478,000 USD.
Get free Agios Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,240,000 USD
- Operating income
- -389,047,000 USD
- Net income
- -231,801,000 USD
- Operating cash flow
- -309,478,000 USD